Ivim Health raises concern over US FDA’s arbitrary critical deadline comes; submits Amicus brief to fighting patient access to GLP-1 medications: Columbus, Ohio Thursday, Februa ...
A charity boss who once tipped the scales at more than 28st says weight-loss injections have changed the way he thinks about ...
Another shop will be closing on Huddersfield high street after 90 years. Beaverbrooks has confirmed that it will be closing on Sunday, April 6 after been deemed 'unviable' by its bosses to stay open ...
Ozempic and Wegovy has been prescribed to Yorkshire patients hundreds of times in the past year - and it's not for weightloss ...
Truist Securities reaffirmed its Buy rating and $1,038.00 price target for Eli Lilly and Company (NYSE:LLY) shares, with analyst targets ranging from $580 to $1,190. The company, which has ...
A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...
Doctors emphasize the importance of regular checkups with a primary care provider and simple tests that could detect heart ...
The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...
Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...
Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...
Novo’s newest GLP-1, CagriSema, is the first big test of Novo Nordisk’s future as the leader in the obesity treatment market.
If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your body to burn more fat instead and hang on to muscle. There’s also a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results